+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-08-23Number of Pages: 145

Subcutaneous Immunoglobulin Market (Application - Primary Immunodeficiency Diseases and Secondary Immunodeficiency Diseases; End User - Hospitals, Clinics, and Home Care) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Section 1 Preface 
1.1 Report Scope and Market Segmentation 
1.2 Research Highlights

Section 2 Assumptions and Research Methodology 
2.1 Assumptions
2.2 Research Methodology

Section 3 Executive Summary
3.1 Global Subcutaneous Immunoglobulin (SCIG): Market Snapshot
3.2 Market Share Analysis by Region, 2015
3.3 Global Subcutaneous Immunoglobulin (SCIG) Market : Opportunity Map

Section 4 Market Overview
4.1 Indication Overview
4.2 Global Subcutaneous Immunoglobulin (SCIG) Market : Key Industry Developments
4.3 Global Subcutaneous Immunoglobulin (SCIG) Market : Market Indicators

Section 5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
      5.2.1 Rise in prevalence of autoimmune disorders
      5.2.2 Increase in global geriatric population
      5.2.3 Growing usage in off-label indications
      5.2.4 Improved technology for production and purification methods
      5.2.5 Favorable government initiatives and approvals
      5.2.6 Increased convenience and patient satisfaction for SCIG compared to IVIG
5.3 Restraints
      5.3.1 High cost of treatment
      5.3.2 Supply demand gaps
5.4 Global Subcutaneous Immunoglobulin (SCIG) Market : Opportunity Analysis
5.5 Opportunities
      5.5.1 Innovations in administration of subcutaneous immunoglobulin
      5.5.2 Increasing global plasma yield to offer significant opportunities to new entrants
5.6 Key Trends
5.7 Porter’s Analysis
5.8 Global Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, 2014–2024
5.9 Value Chain Analysis
5.10 Subcutaneous Immunoglobulin (SCIG) Market Outlook

Section 6 Subcutaneous Immunoglobulin (SCIG) Market Analysis, by Application
6.1 Key Findings
6.2 Introduction
6.3 Global Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Application
6.4 Global Subcutaneous Immunoglobulin (SCIG) Market Forecast, by Application
6.5 Global Subcutaneous Immunoglobulin (SCIG) Market Analysis, by Application (1/2)
      6.5.1 Primary Immunodeficiency Diseases
      6.5.2 Secondary Immunodeficiency Diseases      
      6.5.3 Others
6.6 Global Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by Application
6.7 Key Trends

Section 7 Subcutaneous Immunoglobulin (SCIG) Market Analysis, by End-user
7.1 Key Findings
7.2 Introduction
7.3 Global Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by End-user
7.4 Global Subcutaneous Immunoglobulin (SCIG) Market Forecast, by End-user
      7.4.1 Hospitals
      7.4.2 Clinics
      7.4.3 Homecare Settings
7.5 Market Attractiveness Analysis, by End-user
7.6 Key Trends

Section 8 Subcutaneous Immunoglobulin (SCIG) Market Analysis, by Region
8.1 Global Subcutaneous Immunoglobulin (SCIG) Market Snapshot, by Country
8.2 Global Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Region
8.3 Subcutaneous Immunoglobulin (SCIG) Market Forecast, by Region
8.4 Market Attractiveness Analysis, by Region

Section 9 North America Subcutaneous Immunoglobulin (SCIG) Market Analysis
9.1 Key Findings
9.2 Market Overview
9.3 North America Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Application
9.4 North America Subcutaneous Immunoglobulin (SCIG) Market Forecast, by Application 
9.5 North America Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by End-user
9.6 North America Subcutaneous Immunoglobulin (SCIG) Market Forecast, by End-user
9.7 North America Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Country
9.8 North America Subcutaneous Immunoglobulin (SCIG) Market Forecast, by Country
9.9 North America Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis 
9.10 Market Trends

Section 10 Europe Subcutaneous Immunoglobulin (SCIG) Market Analysis
10.1 Key Findings
10.2 Market Overview
10.3 Europe Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Application
10.4 Europe Subcutaneous Immunoglobulin (SCIG) Market Forecast, by Application 
10.5 Europe Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by End-user
10.6 Europe Subcutaneous Immunoglobulin (SCIG) Market Forecast, by End-user
10.7 Europe Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Country
10.8 Europe Subcutaneous Immunoglobulin (SCIG) Market Forecast, by Country
10.9 Europe Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis 
10.10 Market Trends

Section 11 Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Analysis
11.1 Key Findings
11.2 Market Overview
11.3 Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Application
11.4 Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Forecast, by Application 
11.5 Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by End-user
11.6 Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Forecast, by End-user
11.7 Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Country
11.8 Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Forecast, by Country
11.9 Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis 
11.10 Market Trends

Section 12 Latin America Subcutaneous Immunoglobulin (SCIG) Market Analysis
12.1 Key Findings
12.2 Market Overview
12.3 Latin America Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Application
12.4 Latin America Subcutaneous Immunoglobulin (SCIG) Market Forecast, by Application 
12.5 Latin America Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by End-user
12.6 Latin America Subcutaneous Immunoglobulin (SCIG) Market Forecast, by End-user
12.7 Latin America Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Country
12.8 Latin America Subcutaneous Immunoglobulin (SCIG) Market Forecast, by Country
12.9 Latin America Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis 
12.10 Market Trends

Section 13 Middle East & Africa Subcutaneous Immunoglobulin (SCIG) Market Analysis
13.1 Key Findings
13.2 Market Overview
13.3 Middle East & Africa Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Application
13.4 Middle East & Africa Subcutaneous Immunoglobulin (SCIG) Market Forecast, by Application 
13.5 Middle East & Africa Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by End-user
13.6 Middle East & Africa Subcutaneous Immunoglobulin (SCIG) Market Forecast, by End-user
13.7 Middle East & Africa Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Country
13.8 Middle East & Africa Subcutaneous Immunoglobulin (SCIG) Market Forecast, by Country
13.9 Middle East & Africa Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis 
13.10 Market Trends

Section 14 Competition Landscape
14.1 Global Subcutaneous Immunoglobulin Market Share Analysis, By Company, (2016)
14.2 Competition Matrix
14.3 Competition Landscape
      14.3.1 Baxalta Incorporated 
               14.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
               14.3.1.2 Product Portfolio
               14.3.1.3 SWOT Analysis
               14.3.1.4 Financial Overview
               14.3.1.5 Strategic Overview
      14.3.2 Biotest AG
               14.3.2.1 Company Overview (HQ, Business Segments, Employee Strength)
               14.3.2.2 Product Portfolio
               14.3.2.3 SWOT Analysis
               14.3.2.4 Financial Overview
               14.3.2.5 Strategic Overview
      14.3.3 CSL Behring
               14.3.3.1 Company Overview (HQ, Business Segments, Employee Strength)
               14.3.3.2 Product Portfolio
               14.3.3.3 SWOT Analysis
               14.3.3.4 Financial Overview
               14.3.3.5 Strategic Overview
      14.3.4 Grifols, S.A. 
               14.3.4.1 Company Overview (HQ, Business Segments, Employee Strength)
               14.3.4.2 Product Portfolio
               14.3.4.3 SWOT Analysis
               14.3.4.4 Financial Overview
               14.3.4.5 Strategic Overview
      14.3.5 Talecris Biotherapeutics, Inc.
               14.3.5.1 Company Overview (HQ, Business Segments, Employee Strength)
               14.3.5.2 Product Portfolio
               14.3.5.3 SWOT Analysis
               14.3.5.4 Financial Overview
               14.3.5.5 Strategic Overview
      14.3.6  Kedrion S.p.A. 
               14.3.6.1 Company Overview (HQ, Business Segments, Employee Strength)
               14.3.6.2 Product Portfolio
               14.3.6.3 SWOT Analysis
               14.3.6.4 Financial Overview
               14.3.6.5 Strategic Overview
      14.3.7 Octapharma AG 
               14.3.7.1 Company Overview (HQ, Business Segments, Employee Strength)
               14.3.7.2 Product Portfolio
               14.3.7.3 SWOT Analysis
               14.3.7.4 Financial Overview
               14.3.7.5 Strategic Overview
      14.3.8 Shire Plc
               14.3.8.1 Company Overview (HQ, Business Segments, Employee Strength)
               14.3.8.2 Product Portfolio
               14.3.8.3 SWOT Analysis
               14.3.8.4 Financial Overview
               14.3.8.5 Strategic Overview

List of Figures

Figure 01: Global Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, 2016–2024
Figure 02: Global Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Application, 2016 and 2024
Figure 03: Global Primary Immunodeficiency Diseases Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 04: Global Secondary Immunodeficiency Diseases Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 05: Global Secondary Immunodeficiency Diseases Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2014–2024
Figure 06: Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by Application
Figure 07: Global Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by End-user, 2016 and 2024
Figure 08: Global Hospitals Market Revenue, US$ Mn, 
Figure 09: Global Clinics Market Revenue, US$ Mn,
Figure 10: Global Home Care Settings Market Revenue, US$ Mn, 2014–2024
Figure 11: Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by End-user
Figure 12: Global Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Region, 2016 and 2024
Figure 13: Global Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by Region
Figure 14: North America Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, 2016–2024
Figure 15: North America Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by Country
Figure 16: North America Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Application, 2016 and 2024
Figure 17: North America Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by End-user, 2016 and 2024
Figure 18: North America Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Country, 2016 and 2024
Figure 19: North America Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by Application 
Figure 20: North America Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by End-user
Figure 21: Europe Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 22: Europe Subcutaneous Immunoglobulin Market Attractiveness Analysis, by Country
Figure 23: Europe Subcutaneous Immunoglobulin Market Value Share Analysis, by Application, 2016 and 2024
Figure 24: Europe Subcutaneous Immunoglobulin Market Value Share Analysis, by End-user, 2016 and 2024
Figure 25: Europe Subcutaneous Immunoglobulin Market Value Share Analysis, by Country, 2016 and 2024
Figure 26: Europe Subcutaneous Immunoglobulin Market Attractiveness Analysis, by Application
Figure 27: Europe Subcutaneous Immunoglobulin Market Attractiveness Analysis, by End-user
Figure 28: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, 2014–2024
Figure 29: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by Country
Figure 30: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Application, 2016 and 2024
Figure 31: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by End-user, 2016 and 2024
Figure 32: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Country, 2016 and 2024
Figure 33: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by Application
Figure 34: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by End-user
Figure 35: Latin America subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, 2014–2024
Figure 36: Latin America Market Attractiveness Analysis, by Country
Figure 37: Latin America Market Value Share Analysis, by Application, 2016 and 2024
Figure 38: Latin America Market Value Share Analysis, by End-user, 2016 and 2024
Figure 39: Latin America Market Value Share Analysis, by Country, 2016 and 2024
Figure 40: : Latin America Market Attractiveness Analysis, by Application
Figure 41: : Latin America Market Attractiveness Analysis, by End-user
Figure 42: Middle East & Africa Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2014–2024
Figure 43: Middle East & Africa Subcutaneous Immunoglobulin Market Attractiveness Analysis, by Country
Figure 44: Middle East & Africa Subcutaneous Immunoglobulin Market Value Share Analysis, by Application, 2016 and 2024
Figure 45: Middle East & Africa Subcutaneous Immunoglobulin Market Value Share Analysis, by End-user, 2016 and 2024
Figure 46: Middle East & Africa Subcutaneous Immunoglobulin Market Value Share Analysis, by Country, 2016 and 2024
Figure 47 : Middle East & Africa Subcutaneous Immunoglobulin Market Attractiveness Analysis, by Application
Figure 48 : Middle East & Africa Subcutaneous Immunoglobulin Market Attractiveness Analysis, by End-user
Figure 49: Global Subcutaneous Immunoglobulin (SCIG) Market Share Analysis, by Company (2016)

 

List of Tables 

Table 01: Global Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Application, 2016–2024
Table 02: Global Subcutaneous Immunoglobulin (IVIG) Market Size (US$ Mn) Forecast, by End-user, 2016–2024
Table 03: Global Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Region, 2016–2024
Table 04: North America Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Application, 2016–2024
Table 05: North America Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by End-user, 2016–2024
Table 06: North America Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 07: Europe Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast, by Application, 2016–2024
Table 08: Europe Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast, by End-user, 2016–2024
Table 09: Europe Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 10: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Application, 2016–2024
Table 11: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by End-user, 2016–2024
Table 12: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 13: Latin America subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Application, 2016–2024
Table 14: Latin America subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by End-user, 2014–2024
Table 15: Latin America subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 16: Middle East & Africa Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast, by Application, 2016–2024
Table 17: Middle East & Africa Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast, by End-user, 2014–2024
Table 18: Middle East & Africa Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast, by Country, 2014–2024


 
 
Back To Top